Dalila Scaturro | Biological Networks | Best Researcher Award

Published on by Network Science

Best Researcher Award

Dalila Scaturro
Università degli Studi di Palermo, Italy

Dalila Scaturro
Affiliation Università degli Studi di Palermo
Country Italy
Scopus ID 56156164000
Documents 56
Citations 665
h-index 15
Subject Area Biological Networks
Event International Research Awards on Network Science & Graph Analytics
ORCID 0000-0002-5035-2288

Dalila Scaturro is an Italian researcher affiliated with the Università degli Studi di Palermo whose scholarly activities encompass rehabilitation medicine, musculoskeletal disorders, peripheral neuropathies, and interdisciplinary biomedical research. Her publication portfolio demonstrates sustained engagement with evidence-based rehabilitation approaches and clinical outcomes assessment. Through collaborative research efforts, she has contributed to studies addressing pain management, robotic-assisted orthopedic rehabilitation, systematic reviews, and rehabilitation sciences, supporting advancements in patient-centered healthcare and translational clinical practice.[1]

Abstract

This article summarizes the academic profile and research achievements of Dalila Scaturro. Her work is characterized by multidisciplinary collaboration across rehabilitation medicine, musculoskeletal health, orthopedic recovery, and neurological rehabilitation. Through clinical investigations and systematic reviews, she has contributed to the understanding of therapeutic interventions and rehabilitation outcomes while supporting evidence-based healthcare practices.[2]

Keywords

Rehabilitation Medicine, Biological Networks, Musculoskeletal Disorders, Clinical Research, Peripheral Neuropathies, Evidence-Based Healthcare, Orthopedic Rehabilitation, Systematic Reviews.

Introduction

Modern rehabilitation science increasingly relies on interdisciplinary collaboration and clinical evidence. Dalila Scaturro has participated in investigations examining rehabilitation outcomes, pain management strategies, and orthopedic interventions. Her scholarly record reflects a commitment to translating scientific findings into practical applications that may improve patient recovery and functional performance.[3]

Research Profile

With 56 indexed documents, 665 citations, and an h-index of 15, Scaturro has established a measurable scholarly presence within biomedical and rehabilitation research. Her publication record demonstrates engagement with clinical investigations, systematic reviews, and multidisciplinary healthcare studies. These metrics indicate sustained scientific productivity and visibility within her research community.[1]

Research Contributions

  • Investigation of exercise and mesotherapy approaches for neck pain associated with fibromyalgia.
  • Assessment of rehabilitation outcomes following robot-assisted total knee arthroplasty.
  • Contribution to systematic reviews on peripheral neuropathy rehabilitation and nerve repair.
  • Evaluation of intra-articular botulinum toxin interventions for knee osteoarthritis.
  • Research on scoliosis, body mass relationships, and musculoskeletal health outcomes.

Publications

  1. Neck pain in Fibromyalgia: treatment with exercise and mesotherapy. Biomedicines, 2023.
  2. Rehabilitation approach in robot assisted total knee arthroplasty: an observational study. BMC Musculoskeletal Disorders, 2023.
  3. The Role of Physical Exercise and Rehabilitative Implications in the Process of Nerve Repair in Peripheral Neuropathies: A Systematic Review. Diagnostics, 2023.
  4. Intra-Articular Injection of Botulinum Toxin for the Treatment of Knee Osteoarthritis. International Journal of Molecular Sciences, 2023.
  5. Is there relationship between idiopathic scoliosis and body mass? A scoping review. Nutrients, 2022.

Research Impact

The research contributions associated with Scaturro demonstrate relevance to clinical rehabilitation, musculoskeletal medicine, and healthcare outcomes. Her studies support evidence synthesis and clinical decision-making through observational research and systematic reviews. The citation record further indicates scholarly engagement with her published findings across related biomedical disciplines.[4]

Award Suitability

Dalila Scaturro’s publication output, citation performance, and collaborative research contributions align with the objectives of the International Research Awards on Network Science & Graph Analytics. Her multidisciplinary work demonstrates scientific rigor, sustained productivity, and contributions to healthcare knowledge dissemination. These characteristics support consideration for academic recognition within international research forums.[5]

Conclusion

Dalila Scaturro has developed a research portfolio focused on rehabilitation sciences, orthopedic recovery, and evidence-based clinical practice. Her scholarly activities, publication record, and measurable research impact illustrate continued engagement with contemporary biomedical challenges and support her standing within the academic community.[6]

References

  1. Elsevier. (n.d.). Scopus author details: Dalila Scaturro, Author ID 56156164000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56156164000
  2. Scaturro, D., et al. (2023). Neck pain in Fibromyalgia: treatment with exercise and mesotherapy. Biomedicines.
  3. Scaturro, D., et al. (2023). Rehabilitation approach in robot assisted total knee arthroplasty: an observational study. BMC Musculoskeletal Disorders.
  4. Chiaramonte, R., et al. (2023). The Role of Physical Exercise and Rehabilitative Implications in the Process of Nerve Repair in Peripheral Neuropathies. Diagnostics.
  5. Sconza, C., et al. (2023). Intra-Articular Injection of Botulinum Toxin for the Treatment of Knee Osteoarthritis. International Journal of Molecular Sciences.
  6. Scaturro, D., et al. (2022). Is there relationship between idiopathic scoliosis and body mass? A scoping review. Nutrients.

Dexin Wang | Biological Networks | Research Excellence Award

Published on by Network Science

Dr. Dexin Wang | Biological Networks | Research Excellence Award

Shanghai Advanced Research Institute, Chinese Academy of Sciences | China

Dr. Dexin Wang is a dedicated researcher in the field of bioactive and biochemical materials, holding a PhD in Bioactive Materials from Jeonbuk National University, a Master’s degree in Biochemical Engineering from Yanshan University, and a Bachelor’s degree in Biological Engineering from Jilin Institute of Chemical Technology. He is currently an Assistant Researcher at the Green Chemical Research Centre, Shanghai Advanced Research Institute, Chinese Academy of Sciences, following his postdoctoral work at the Tianjin Institute of Industrial Biotechnology. His research experience spans metabolic pathway analysis, microbial fermentation systems, metabolic engineering, and synthetic biology, including major contributions such as constructing microbial strains for optimized glucose oxidation pathways, developing high-efficiency microbial production of 1,3-propanediol, engineering recombinant E. coli for industrial levan production, advancing γ-PGA biosynthesis through strain improvement and fermentation optimization, and leading the microbial synthesis of high-molecular-weight hyaluronic acid through pathway construction, by-product reduction, multi-enzyme assembly, and membrane-level mechanism analysis. He has participated in multiple national and regional scientific projects and served as the principal investigator for synthetic-biology-based high-molecular-weight hyaluronic acid production. His research interests include metabolite synthesis, recombinant protein expression, microbial cell factory construction, fermentation process optimization, microbial gene editing, and nucleic acid preservation. Dr. Wang is proficient in molecular biology, protein engineering, CRISPR/Cas-based genetic editing, and advanced fermentation techniques, and is skilled in bioinformatics and scientific data analysis, supported by strong English proficiency and excellent collaboration and communication abilities.

Profiles: Scopus

Featured Publications

"Electrogenetic depolymerization of poly-gamma glutamic acid in Bacillus subtilis biofilms", Dexin Wang, Journal of Power Sources, 2025.

"Corrigendum: Jejubacter calystegiae gen. nov., sp. nov., moderately halophilic, a new member of the family Enterobacteriaceae, isolated from beach morning glory", Dexin Wang, Journal of Power Sources, 2025.

Nikhil Sudhir Sathe | Biological Networks | Best Researcher Award

Published on by Network Science

Dr. Nikhil Sudhir Sathe | Biological Networks | Best Researcher Award

Reliance Life Sciences Pvt Ltd | India

Dr. Nikhil Sudhir Sathe (PhD), currently associated with Laboratory Animal Research Services (LARS), is a distinguished researcher with over 20 years of expertise in drug discovery and preclinical evaluation of new chemical entities. His extensive professional experience encompasses in vitro genotoxicology, cell and microbial culture (aerobic, anaerobic, and viral systems including rabies virus), and small laboratory animal studies. Throughout his career at Reliance Life Sciences, Vimta Labs, Dabur Research Centre, and Wockhardt Research Centre, Dr. Sathe has demonstrated exceptional proficiency in GLP-compliant laboratory practices, including bacterial reverse mutation, chromosomal aberration, micronucleus, ELISA, cytotoxicity, and microbial monitoring assays. His early research contributions involved innovative in vitro models for evaluating the efficacy of antimicrobial and cosmetic products. Academically, he holds a Master’s and Bachelor’s degree in Microbiology from Shivaji University, Kolhapur, both with distinction. Dr. Sathe has contributed significantly to scientific literature with publications in reputed journals such as Vaccine, Microbial Pathogenesis, Infectious Medicine, and BioMed, focusing on bacteriophage therapy and vaccine development against multidrug-resistant pathogens and SARS-CoV-2. His scholarly achievements are complemented by active participation in national conferences and workshops, reflecting his deep commitment to advancing microbiological and biomedical research.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"Unveiling Lytic Bacteriophages as Promising Biotherapeutics for the Control of Multidrug-Resistant Pseudomonas aeruginosa", CS Nikhil Sathe, Eugene Athan, Arnab Kapat, BioMed, 2025.

"Safety, immunogenicity and efficacy of Relcovax®, a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus", N Sathe, S Shaikh, M Bhavsar, L Parte, A Gadiparthi, S Kad, S Sensarma, Vaccine, 2024.

"Bacteriophage vB_kpnS-Kpn15: Unveiling its potential triumph against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae-Unraveling efficacy through innovative", N Sathe, C Suphioglu, E Athan, A Kapat, Microbial Pathogenesis, 2024.

"Pseudomonas aeruginosa: Infections and novel approaches to treatment “Knowing the enemy” the threat of Pseudomonas aeruginosa and exploring novel approaches to treatment", N Sathe, P Beech, L Croft, C Suphioglu, A Kapat, E Athan, Infectious medicine 2, 2023.

"Development of a novel therapy using bacteriophages: An alternative to antibiotics", NS Sathe, Deakin University, 2023.

Fatemeh Safari | Biological Networks | Best Researcher Award

Published on by Network Science

Dr. Fatemeh Safari | Biological Networks | Best Researcher Award

Assistant Professor at Shiraz University of Medical Sciences, Iran📖

Dr. Fatemeh Safari is an Assistant Professor at the Diagnostic Laboratory Science and Technology Research Center, Shiraz University of Medical Sciences, Iran. She holds a PhD in Medical Biotechnology from Tabriz University of Medical Sciences, where she also completed her MSc in the same field. Her academic journey began with a BSc in Nursing from Shiraz University of Medical Sciences. With expertise in genome editing, cell culture, and protein biochemistry, Dr. Safari has contributed significantly to the field of biotechnology, specializing in gene expression regulation and improving recombinant CHO cell productivity.

Profile

Scopus Profile

Orcid Profile

Google Scholar Profile

Education Background🎓

  • PhD in Medical Biotechnology
    Tabriz University of Medical Sciences, Tabriz, Iran (2015-2021)
  • MSc in Medical Biotechnology
    Tabriz University of Medical Sciences, Tabriz, Iran (2010-2013)
    Top student in the program, elected student by the organization for Gifted and Talented Education
  • BSc in Nursing
    Shiraz University of Medical Sciences, Shiraz, Iran (2001-2004)
    Elected student by the organization for Gifted and Talented Education

Professional Experience🌱

  • Assistant Professor, Diagnostic Laboratory Science and Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran (2024–Present)
    In charge of the cell culture room, designing and implementing research projects, and mentoring MSc and Ph.D. students.
  • Senior Researcher, Diagnostic Laboratory Science and Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran (2020–2023)
    Led research in genome editing, cell culture, and protein biochemistry techniques.
  • Laboratory Assistant, R&D Applied Drug Research Center, Tabriz University of Medical Sciences, Tabriz, Iran (2013–2014)
    Gained hands-on experience in animal studies, cell culture, and immunization techniques.
  • Emergency Medical Technician, EMS and Disaster Management Center, Shiraz, Fars, Iran (2005–2013)
    Trained in resuscitation and participated in disaster and emergency medical events.
Research Interests🔬

Dr. Safari’s research primarily focuses on genome editing using the CRISPR/Cas9 system, regulation of gene expression, and the enhancement of CHO cell productivity. She is also dedicated to advancing protein expression and purification techniques, particularly in the fields of molecular cloning and cell-based assays. Furthermore, Dr. Safari investigates small animal models and stem cell culture for therapeutic applications.

Author Metrics

Dr. Safari has contributed to multiple research projects and publications in the field of medical biotechnology. Her work in CRISPR gene editing and cell culture technologies has been widely recognized, and she actively participates in academic workshops on molecular biology and biotechnology techniques. Her teaching experience includes mentoring graduate and Ph.D. students, and she is an expert in advanced laboratory techniques and molecular cellular biology.

Publications Top Notes 📄

1. CRISPR Cpf1 Proteins: Structure, Function, and Implications for Genome Editing

  • Authors: F. Safari, K. Zare, M. Negahdaripour, M. Barekati-Mowahed, Y. Ghasemi
  • Journal: Cell & Bioscience
  • Volume: 9
  • Pages: 1-21
  • Year: 2019
  • Citations: 198
  • Summary: This paper explores the CRISPR/Cpf1 system, a novel genome-editing tool, and its applications in genetic engineering. It provides an in-depth look at the structure and functions of the Cpf1 protein and its potential advantages over other CRISPR systems like Cas9.

2. Overview of Albumin and Its Purification Methods

  • Authors: R. Raoufinia, A. Mota, N. Keyhanvar, F. Safari, S. Shamekhi, J. Abdolalizadeh
  • Journal: Advanced Pharmaceutical Bulletin
  • Volume: 6
  • Issue: 4
  • Pages: 495
  • Year: 2016
  • Citations: 165
  • Summary: This review covers the properties of albumin, a critical protein in pharmaceutical and medical applications, and discusses various techniques for its purification, emphasizing its importance in therapeutic use.

3. Immunotoxins in Cancer Therapy: Review and Update

  • Authors: B. Akbari, S. Farajnia, S. Ahdi Khosroshahi, F. Safari, M. Yousefi, …
  • Journal: International Reviews of Immunology
  • Volume: 36
  • Issue: 4
  • Pages: 207-219
  • Year: 2017
  • Citations: 149
  • Summary: This paper provides an overview of immunotoxins and their evolving role in cancer immunotherapy. It reviews the latest developments in immunotoxin-based treatments, which combine targeted antibody therapy with toxic agents to destroy cancer cells.

4. CRISPR System: A High-Throughput Toolbox for Research and Treatment of Parkinson’s Disease

  • Authors: F. Safari, G. Hatam, A.B. Behbahani, V. Rezaei, M. Barekati-Mowahed, …
  • Journal: Cellular and Molecular Neurobiology
  • Volume: 40
  • Pages: 477-493
  • Year: 2020
  • Citations: 65
  • Summary: This article reviews the use of the CRISPR/Cas9 gene-editing system in the context of Parkinson’s disease research and therapy. It highlights high-throughput methods for studying the disease and potential CRISPR-based treatments.

5. CRISPR and Personalized Treg Therapy: New Insights into the Treatment of Rheumatoid Arthritis

  • Authors: F. Safari, S. Farajnia, M. Arya, H. Zarredar, A. Nasrolahi
  • Journal: Immunopharmacology and Immunotoxicology
  • Volume: 40
  • Issue: 3
  • Pages: 201-211
  • Year: 2018
  • Citations: 65
  • Summary: This review discusses the role of regulatory T cells (Tregs) in the immune system and how CRISPR-based technologies can be used for personalized therapies to treat autoimmune diseases, particularly rheumatoid arthritis.

Conclusion

Dr. Fatemeh Safari is a highly deserving candidate for the Best Researcher Award, given her groundbreaking contributions to medical biotechnology, particularly in genome editing, cell culture, and protein biochemistry. Her research in CRISPR/Cas9 technology, its applications in disease treatment, and her dedication to teaching and mentoring future scientists are noteworthy. While there are opportunities for her to expand the practical applications and international reach of her work, her academic and research achievements already place her at the forefront of her field. The recognition through the Best Researcher Award would not only honor her past achievements but also serve as a platform for the next stage of her career, allowing her to make even greater strides in biotechnology and medical research.